耐药结核病的息治疗:管理中的一个被忽视的组成部分
Deependra Kumar Rai1, Priya Sharma1
1Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
Indian journal of palliative care
|December 7, 2023
概括
息治疗对耐药结核病 (DRTB) 患者至关重要,它可以在疾病的各个阶段缓解痛苦,而不仅仅是生命末期. 整合结核病医护人员的息护理培训对于改善患者生活质量至关重要.
科学领域:
- 公共卫生 公共卫生
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
背景情况:
- 耐药结核病 (DRTB) 通常被认为是绝症,导致患者和护理人员遭受重大痛苦.
- 息治疗经常被误解为仅仅是生命终端治疗,忽视了它在疾病早期阶段的作用.
- DRTB患者的综合需求,包括症状管理和心理社会支持,往往没有得到满足.
研究的目的:
- 强调息治疗在治疗耐药结核病 (DRTB) 中的关键作用.
- 澄清除了生命终端支持之外的息护理的更广泛范围.
- 倡导将息治疗原则纳入DRTB管理策略.
主要方法:
- 关于息治疗原则及其在传染病中的应用的文献综述.
- 分析当前对DRTB的息护理的看法和做法.
- 确定DRTB息护理干预的关键领域.
主要成果:
- 息治疗显著缓解DRTB患者及其照顾者的难以治疗的症状和痛苦.
- 有效的息治疗可以提高DRTB患者的整体生活质量.
- 关于息护理的误解限制了其在DRTB管理中的实施.
结论:
- 息治疗是整体DRTB管理的组成部分,解决身体,心理和精神上的痛苦.
- 迫切需要对结核病医疗保健工作者进行基本息治疗方面的全面培训.
- 将息治疗纳入现有的结核病医疗保健系统对于改善患者的治疗结果和护理人员的支持至关重要.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
181
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
181
Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis II
242
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
242
Pneumonia IV: Management
333
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
333
Pulmonary Tuberculosis III
336
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
336


